Krüppel-Like Factor 4 Transcriptionally Regulates TGF-β1 and Contributes to Cardiac Myofibroblast Differentiation

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Zhang, Yi ^a   Wang, Ying ^a   Liu, Yan ^a   Wang, Nanping ^a   Qi, Yongfen ^a   Du, Jie ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN II; COLLAGEN; KRUPPEL LIKE FACTOR 4; TRANSFORMING GROWTH FACTOR BETA1; KRUPPEL LIKE FACTOR;

ANIMAL CELL; ARTICLE; CARDIAC FIBROBLAST; CARDIAC MYOFIBROBLAST; CELL ACTIVATION; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROBLAST; GENE DELETION; MOUSE; MUTAGENESIS; MUTATIONAL ANALYSIS; MYOFIBROBLAST; NEWBORN; NONHUMAN; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; UPREGULATION; ANIMAL; BIOSYNTHESIS; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEART MUSCLE; KNOCKOUT MOUSE; MALE; METABOLISM; MYOBLAST; TRANSCRIPTION INITIATION;

ANGIOTENSIN II; ANIMALS; CELL DIFFERENTIATION; COLLAGEN; FIBROBLASTS; GENE EXPRESSION REGULATION; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MALE; MICE; MICE, KNOCKOUT; MYOBLASTS, CARDIAC; MYOCARDIUM; MYOFIBROBLASTS; PROMOTER REGIONS, GENETIC; TRANSCRIPTIONAL ACTIVATION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84877006414     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0063424     Document Type: Article

References (41)

1. Ferrario CM, Strawn WB, (2006) Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 98: 121-128.
2. Mehta PK, Griendling KK, (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292: C82-97.
3. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, et al. (2007) The myofibroblast: one function, multiple origins. Am J Pathol 170: 1807-1816.
4. Berk BC, Fujiwara K, Lehoux S, (2007) ECM remodeling in hypertensive heart disease. J Clin Invest 117: 568-575.
5. Massague J, (2000) How cells read TGF-beta signals. Nat Rev Mol Cell Biol 1: 169-178.
6. Manabe I, Shindo T, Nagai R, (2002) Gene expression in fibroblasts and fibrosis: involvement in cardiac hypertrophy. Circ Res 91: 1103-1113.
7. Dobaczewski M, Chen W, Frangogiannis NG, (2011) Transforming growth factor (TGF)-beta signaling in cardiac remodeling. J Mol Cell Cardiol 51: 600-606.
8. Sadoshima J, Izumo S, (1993) Molecular characterization of angiotensin II - induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 73: 413-423.
9. Zhang L, Ma Y, Zhang J, Cheng J, Du J, (2005) A new cellular signaling mechanism for angiotensin II activation of NF-kappaB: An IkappaB-independent, RSK-mediated phosphorylation of p65. Arterioscler Thromb Vasc Biol 25: 1148-1153.
10. Naftilan AJ, Pratt RE, Dzau VJ, (1989) Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 83: 1419-1424.
11. Naftilan AJ, Gilliland GK, Eldridge CS, Kraft AS, (1990) Induction of the proto-oncogene c-jun by angiotensin II. Mol Cell Biol 10: 5536-5540.
12. Taubman MB, Berk BC, Izumo S, Tsuda T, Alexander RW, et al. (1989) Angiotensin II induces c-fos mRNA in aortic smooth muscle. Role of Ca2+ mobilization and protein kinase C activation. J Biol Chem 264: 526-530.
13. Hamaguchi A, Kim S, Izumi Y, Zhan Y, Yamanaka S, et al. (1999) Contribution of extracellular signal-regulated kinase to angiotensin II-induced transforming growth factor-beta1 expression in vascular smooth muscle cells. Hypertension 34: 126-131.
14. Feng W, Chumley P, Hua P, Rezonzew G, Jaimes D, et al. (2012) Role of the Transcription Factor Erythroblastosis Virus E26 Oncogen Homolog-1 (ETS-1) as Mediator of the Renal Proinflammatory and Profibrotic Effects of Angiotensin II. Hypertension 60: 1226-1233.
15. Kaczynski J, Cook T, Urrutia R, (2003) Sp1- and Kruppel-like transcription factors. Genome Biol 4: 206.
16. Fisch S, Gray S, Heymans S, Haldar SM, Wang B, et al. (2007) Kruppel-like factor 15 is a regulator of cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A 104: 7074-7079.
17. Wang B, Haldar SM, Lu Y, Ibrahim OA, Fisch S, et al. (2008) The Kruppel-like factor KLF15 inhibits connective tissue growth factor (CTGF) expression in cardiac fibroblasts. J Mol Cell Cardiol 45: 193-197.
18. Haldar SM, Ibrahim OA, Jain MK, (2007) Kruppel-like Factors (KLFs) in muscle biology. J Mol Cell Cardiol 43: 1-10.
19. Shindo T, Manabe I, Fukushima Y, Tobe K, Aizawa K, et al. (2002) Kruppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling. Nat Med 8: 856-863.
20. Ma F, Li Y, Jia L, Han Y, Cheng J, et al. (2012) Macrophage-stimulated cardiac fibroblast production of IL-6 is essential for TGF beta/Smad activation and cardiac fibrosis induced by angiotensin II. PLoS One 7: e35144.
21. Wang N, Verna L, Chen NG, Chen J, Li H, et al. (2002) Constitutive activation of peroxisome proliferator-activated receptor-gamma suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells. J Biol Chem 277: 34176-34181.
22. Ai W, Liu Y, Langlois M, Wang TC, (2004) Kruppel-like factor 4 (KLF4) represses histidine decarboxylase gene expression through an upstream Sp1 site and downstream gastrin responsive elements. J Biol Chem 279: 8684-8693.
23. Wu X, Cheng J, Li P, Yang M, Qiu S, et al. (2010) Mechano-sensitive transcriptional factor Egr-1 regulates insulin-like growth factor-1 receptor expression and contributes to neointima formation in vein grafts. Arterioscler Thromb Vasc Biol 30: 471-476.
24. Katz JP, Perreault N, Goldstein BG, Lee CS, Labosky PA, et al. (2002) The zinc-finger transcription factor Klf4 is required for terminal differentiation of goblet cells in the colon. Development 129: 2619-2628.
25. Wang W, Huang XR, Canlas E, Oka K, Truong LD, et al. (2006) Essential role of Smad3 in angiotensin II-induced vascular fibrosis. Circ Res 98: 1032-1039.
26. Rosenkranz S, (2004) TGF-beta1 and angiotensin networking in cardiac remodeling. Cardiovasc Res 63: 423-432.
27. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, et al. (1994) Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 330: 1629-1633.
28. Qi G, Jia L, Li Y, Bian Y, Cheng J, et al. (2011) Angiotensin II infusion-induced inflammation, monocytic fibroblast precursor infiltration, and cardiac fibrosis are pressure dependent. Cardiovasc Toxicol 11: 157-167.
29. Yang M, Zheng J, Miao Y, Wang Y, Cui W, et al. (2012) Serum-glucocorticoid regulated kinase 1 regulates alternatively activated macrophage polarization contributing to angiotensin II-induced inflammation and cardiac fibrosis. Arterioscler Thromb Vasc Biol 32: 1675-1686.
30. Force T, Bonventre JV, (1998) Growth factors and mitogen-activated protein kinases. Hypertension 31: 152-161.
31. Lim DS, Lutucuta S, Bachireddy P, Youker K, Evans A, et al. (2001) Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy. Circulation 103: 789-791.
32. Takeda N, Manabe I, Uchino Y, Eguchi K, Matsumoto S, et al. (2010) Cardiac fibroblasts are essential for the adaptive response of the murine heart to pressure overload. J Clin Invest 120: 254-265.
33. Zhang W, Geiman DE, Shields JM, Dang DT, Mahatan CS, et al. (2000) The gut-enriched Kruppel-like factor (Kruppel-like factor 4) mediates the transactivating effect of p53 on the p21WAF1/Cip1 promoter. J Biol Chem 275: 18391-18398.
34. Liu Y, Sinha S, McDonald OG, Shang Y, Hoofnagle MH, et al. (2005) Kruppel-like factor 4 abrogates myocardin-induced activation of smooth muscle gene expression. J Biol Chem 280: 9719-9727.
35. Hamik A, Lin Z, Kumar A, Balcells M, Sinha S, et al. (2007) Kruppel-like factor 4 regulates endothelial inflammation. J Biol Chem 282: 13769-13779.
36. Feinberg MW, Wara AK, Cao Z, Lebedeva MA, Rosenbauer F, et al. (2007) The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiation. EMBO J 26: 4138-4148.
37. Zhou G, Hamik A, Nayak L, Tian H, Shi H, et al. (2012) Endothelial Kruppel-like factor 4 protects against atherothrombosis in mice. J Clin Invest 122: 4727-4731.
38. Yoshida T, Kaestner KH, Owens GK, (2008) Conditional deletion of Kruppel-like factor 4 delays downregulation of smooth muscle cell differentiation markers but accelerates neointimal formation following vascular injury. Circ Res 102: 1548-1557.
39. Li HX, Han M, Bernier M, Zheng B, Sun SG, et al. (2010) Kruppel-like factor 4 promotes differentiation by transforming growth factor-beta receptor-mediated Smad and p38 MAPK signaling in vascular smooth muscle cells. J Biol Chem 285: 17846-17856.
40. Kawai-Kowase K, Ohshima T, Matsui H, Tanaka T, Shimizu T, et al. (2009) PIAS1 mediates TGFbeta-induced SM alpha-actin gene expression through inhibition of KLF4 function-expression by protein sumoylation. Arterioscler Thromb Vasc Biol 29: 99-106.
41. Hu B, Wu Z, Liu T, Ullenbruch MR, Jin H, et al. (2007) Gut-enriched Kruppel-like factor interaction with Smad3 inhibits myofibroblast differentiation. Am J Respir Cell Mol Biol 36: 78-84.